Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of HS-20118

NCT06846710 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

132

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: HS-20118
OTHER: HS-20118 placebo

Sponsor

Jiangsu Hansoh Pharmaceutical Co., Ltd.